TIPRANAVIR vs TISOTUMAB VEDOTIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TIPRANAVIR vs TISOTUMAB VEDOTIN: Safety Overview
| Metric | TIPRANAVIR | TISOTUMAB VEDOTIN |
|---|---|---|
| Total FAERS Reports | 403 | 166 |
| Deaths Reported | 14 | 16 |
| Death Rate | 3.5% | 9.6% |
| Hospitalizations | 261 | 101 |
| Average Patient Age | 48.2 yrs | 50.4 yrs |
| % Female Patients | 82.9% | 88.8% |
| FDA Approval Date | Jun 22, 2005 | N/A |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals,... | SEAGEN INC. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |